|Four New Members Named to NIAID Advisory Council
The National Institute of Allergy and Infectious Diseases (NIAID) today announced
the appointment of four new members to the National Advisory Allergy and Infectious
Diseases Council, its principal advisory body. NIAID is part of the National
Institutes of Health (NIH), an agency within the Department of Health and Human
The council provides recommendations on the conduct and support of research,
including training young scientists and disseminating health information derived
from NIAID research. It embodies a diverse perspective on science, health and
the human impact of disease. The council is composed of physicians, scientists
and representatives of the public who contribute their time and expertise for
a four-year term.
The new council members are Barbara A. Baird, Ph.D., of Cornell University in
Ithaca, NY; Kathryn M. Edwards, M.D., of Vanderbilt University in Nashville,
TN; Martin Rosenberg, Ph.D., of Promega Corporation in Madison, WI; and Megan
Sykes, M.D., of Harvard Medical School in Boston.
Dr. Baird is a professor in the department of chemistry and chemical biology
at Cornell University. She also serves as director of the Nanobiotechnology Center
and is principal investigator for Cornellís training grant in molecular biophysics.
Dr. Bairdís research laboratory uses biochemical and biophysical approaches to
investigate basic mechanisms of cell surface receptors in mediating transmembrane
signals in immune responses. A primary focus of the laboratoryís research is
the high-affinity receptor for immunoglobulin E. She works closely with other
interdisciplinary scientists and engineers to develop new technologies and quantitative
approaches to cell biology problems.
Dr. Edwards is professor of pediatrics at Vanderbilt University. She was the
principal investigator of the NIAID-funded, placebo-controlled influenza efficacy
trial comparing live, attenuated and inactivated influenza vaccines in more than
3,000 volunteers. She is now studying the impact of vaccination programs on disease
burden and leads the NIAID-supported Vaccine and Treatment Evaluation Unit at
Vanderbilt. She served on the Advisory Committee on Immunization Practices of
the Centers for Disease Control and Prevention; the Vaccine and Related Biologic
Products Advisory Committee of the Food and Drug Administration; and the Institute
of Medicine Committee for the Evaluation of the Safety and Effectiveness of the
Dr. Rosenberg is chief scientific officer of Promega Corporation in Wisconsin.
He serves on the boards of directors for Promega Corporation; Cubist Pharmaceuticals;
the Medical College of Wisconsin Research Foundation; Nereus Pharmaceuticals;
Anacor Pharmaceuticals; and Scarab Genomics. He is also on various academic and
industry scientific advisory boards and is editor of both Current Opinions in
Biotechnology and the Journal of Bacteriology. Dr. Rosenberg is an adjunct professor
in the department of bacteriology at the University of Wisconsin and in the department
of biochemistry at the Robert Woods Johnson Medical School.
Dr. Sykes is the Harold and Ellen Danser Professor in the department of surgery
and a professor of medicine at Harvard Medical School. She is an immunologist
and associate director of the Transplantation Biology Research Center at Massachusetts
General Hospital. Her research is in the areas of hematopoietic cell transplantation;
achievement of graft-versus-leukemia effects without graft-versus-host disease;
organ allograft tolerance induction; and xenotransplantation. Dr. Sykes is president
of the International Xenotransplantation Association and a councilor of the International
News releases, fact sheets and other NIAID-related materials are available on
the NIAID Web site at http://www.niaid.nih.gov.
NIAID is a component of the National Institutes of Health, an agency of
the U.S. Department of Health and Human Services. NIAID supports basic and
applied research to prevent, diagnose and treat infectious diseases such as
HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis,
malaria and illness from potential agents of bioterrorism. NIAID also supports
research on transplantation and immune-related illnesses, including autoimmune
disorders, asthma and allergies.
The National Institutes of Health (NIH) — The Nation's Medical Research
Agency — includes 27 Institutes and Centers and is a component of
the U. S. Department of Health and Human Services. It is the primary Federal
agency for conducting and supporting basic, clinical, and translational medical
research, and it investigates the causes, treatments, and cures for both common
and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.